A 3-{[(5-nitro-2-furyl)methylene]amino}-1,3-oxazolidin-2-one DMF (Drug Master File) is a document detailing the whole manufacturing process of 3-{[(5-nitro-2-furyl)methylene]amino}-1,3-oxazolidin-2-one active pharmaceutical ingredient (API) in detail. Different forms of 3-{[(5-nitro-2-furyl)methylene]amino}-1,3-oxazolidin-2-one DMFs exist exist since differing nations have different regulations, such as 3-{[(5-nitro-2-furyl)methylene]amino}-1,3-oxazolidin-2-one USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 3-{[(5-nitro-2-furyl)methylene]amino}-1,3-oxazolidin-2-one DMF submitted to regulatory agencies in the US is known as a USDMF. 3-{[(5-nitro-2-furyl)methylene]amino}-1,3-oxazolidin-2-one USDMF includes data on 3-{[(5-nitro-2-furyl)methylene]amino}-1,3-oxazolidin-2-one's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 3-{[(5-nitro-2-furyl)methylene]amino}-1,3-oxazolidin-2-one USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 3-{[(5-nitro-2-furyl)methylene]amino}-1,3-oxazolidin-2-one suppliers with USDMF on PharmaCompass.